ZA964382B - Lymphotoxin and thrombopoietin for use in the treatment of cancer. - Google Patents

Lymphotoxin and thrombopoietin for use in the treatment of cancer.

Info

Publication number
ZA964382B
ZA964382B ZA9604382A ZA964382A ZA964382B ZA 964382 B ZA964382 B ZA 964382B ZA 9604382 A ZA9604382 A ZA 9604382A ZA 964382 A ZA964382 A ZA 964382A ZA 964382 B ZA964382 B ZA 964382B
Authority
ZA
South Africa
Prior art keywords
lymphotoxin
thrombopoietin
cancer
treatment
Prior art date
Application number
ZA9604382A
Inventor
Grace H W Wong
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA964382B publication Critical patent/ZA964382B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/25—Tumour necrosing factors [TNF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ZA9604382A 1995-06-06 1996-05-29 Lymphotoxin and thrombopoietin for use in the treatment of cancer. ZA964382B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47077695A 1995-06-06 1995-06-06

Publications (1)

Publication Number Publication Date
ZA964382B true ZA964382B (en) 1997-12-01

Family

ID=23868980

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9604382A ZA964382B (en) 1995-06-06 1996-05-29 Lymphotoxin and thrombopoietin for use in the treatment of cancer.

Country Status (8)

Country Link
EP (1) EP0831887B1 (en)
JP (1) JPH11506747A (en)
AU (1) AU697960B2 (en)
CA (1) CA2220336A1 (en)
DE (1) DE69619522T2 (en)
IL (1) IL122466A0 (en)
WO (1) WO1996039171A1 (en)
ZA (1) ZA964382B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102280994B1 (en) * 2019-12-16 2021-07-22 연세대학교 산학협력단 Composition for preventing hair loss or promoting hair growth comprising thrombopoietin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG47030A1 (en) * 1994-01-03 1998-03-20 Genentech Inc Thrombopoietin
US5747023A (en) * 1994-07-01 1998-05-05 Genentech, Inc. Cancer therapy using lymphotoxin

Also Published As

Publication number Publication date
IL122466A0 (en) 1998-06-15
DE69619522D1 (en) 2002-04-04
WO1996039171A1 (en) 1996-12-12
AU5966796A (en) 1996-12-24
DE69619522T2 (en) 2002-10-24
CA2220336A1 (en) 1996-12-12
EP0831887B1 (en) 2002-02-27
JPH11506747A (en) 1999-06-15
EP0831887A1 (en) 1998-04-01
AU697960B2 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
ZA9610784B (en) Quinoline and quinazoline compounds useful in therapy.
HK1010484A1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
HK1020259A1 (en) Composition for use in the treatment and prevention of hyperuricemia.
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU2402395A (en) Cancer treatment and metastasis prevention
EP0685219A3 (en) Hair treatment agent and process for its use.
ZA975288B (en) The use of TCET in the prophylaxis and treatment of allergies.
ZA97741B (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
ZA935575B (en) Therapeutic agent and its use.
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
GB9514816D0 (en) Substances and their medical use
EP0733365A3 (en) Use of benzoquinolin-3-ones for the treatment and prevention of prostatic cancer
AU7688998A (en) Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
ZA964382B (en) Lymphotoxin and thrombopoietin for use in the treatment of cancer.
EP1023076A4 (en) Use of the p-ten suppressor gene in diagnosis and treatment of cancer
AU5871898A (en) Microparticles and their use in cancer treatment
EP0893123A4 (en) Agent for use in the prevention and treatment of disorders associated with various types of ageing
ZA968436B (en) Peptidyl compounds and their therapeutic use.
IL106658A0 (en) Cancer diagnosis and treatment
LV10385B (en) Use of quinons in the treatment of cancer or aids
GB9510961D0 (en) Hemorrhoid treatment and prevention
GB9410969D0 (en) Hemorrhoid treatment and prevention
AUPN650795A0 (en) Encapsulated substances and their use in the treatment of animals
AUPM932194A0 (en) Encapsulated substances and their use in the treatment of animals